Masked Hypertension: A Systematic Review
- PMID: 31477513
- DOI: 10.1016/j.hlc.2019.08.006
Masked Hypertension: A Systematic Review
Abstract
Background: Masked phenomenon, Masked Hypertension (MHT) and Masked Uncontrolled Hypertension (MUCH) is a well-defined clinical entity. However, many aspects of MHT/MUCH remain unclear.
Methods: We systematically reviewed the published literature on MHT/MUCH from 1 January 2000 to 31 June 2018 with a particular focus on epidemiology, clinical significance, evaluation and management. Meta-analyses were performed with respect to prevalence, clinical significance and diagnostic agreement between home blood pressure (HBP) and ambulatory BP (ABP) measurements.
Results: The overall weighted-mean prevalence of masked phenomenon was 11% [9,14]; MHT 10% [9,11]; and MUCH 13% [8,17]. The weighted-mean prevalence when expressed as a proportion of patients with normal office BP was 32% [25,40]; MHT 28% [15,41]; and MUCH 43% [29,57]. The prevalence of masked phenomenon determined by ABP (11% [8,14]) and HBP (13% [9,16]), was similar. However, ABP appeared to have a greater sensitivity, i.e. proportion of patients diagnosed as having MHT/MUCH was greater with ABP than with HBP (22% v 16%, p<0.05), when both methodologies were applied to the same cohort of patients. The prevalence of MHT was influenced by ethnicities and comorbidities, and in case of MUCH by anti-hypertensive treatment. MHT/MUCH was associated with increased risk of fatal and non-fatal cardiac/cerebrovascular events (relative risk [RR] 2.09 [1.80, 2.44]), and the risk was comparable to sustained hypertension (SHT) (RR 2.26 [1.84, 2.78]). The increased risk occurred regardless of the method of out of office BP assessment; the relative risks for ABP and HBP were 2.38 [1.90, 2.98] and 1.90 [1.57, 2.29] respectively. The diagnostic agreement between ABP and HBP was only modest, kappa = 0.46 [0.40, 0.52], even though the percentage agreement was 83%. The evidence for the management of MHT was scant.
Conclusions: MHT/MUCH is a common BP phenotype with a risk profile similar to that of SHT. Therefore, high risk patients should undergo out of office BP assessment, probably both by HBP and ABP, to confirm diagnosis and be considered for treatment.
Keywords: Ambulatory blood pressure; Home blood pressure; Masked hypertension; Masked phenomenon; Masked uncontrolled hypertension.
Copyright © 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Similar articles
-
White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.Stroke. 2013 Jun;44(6):1512-7. doi: 10.1161/STROKEAHA.111.000704. Epub 2013 May 2. Stroke. 2013. PMID: 23640825
-
Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon?Am J Hypertens. 2005 Jun;18(6):772-8. doi: 10.1016/j.amjhyper.2005.01.003. Am J Hypertens. 2005. PMID: 15925734
-
Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.Am J Hypertens. 2013 Jun;26(6):808-15. doi: 10.1093/ajh/hpt021. Epub 2013 Feb 27. Am J Hypertens. 2013. PMID: 23446956 Free PMC article.
-
Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review.High Blood Press Cardiovasc Prev. 2020 Jun;27(3):195-201. doi: 10.1007/s40292-020-00382-1. Epub 2020 May 2. High Blood Press Cardiovasc Prev. 2020. PMID: 32361899 Review.
-
When Office Blood Pressure Is Not Enough: The Case of Masked Hypertension.Am J Hypertens. 2019 Feb 12;32(3):225-233. doi: 10.1093/ajh/hpy183. Am J Hypertens. 2019. PMID: 30508171 Review.
Cited by
-
Heart, Lung and Circulation in the COVID-19 Era: About COVID-19, Not Just About COVID-19.Heart Lung Circ. 2021 Dec;30(12):1792-1799. doi: 10.1016/j.hlc.2021.10.001. Heart Lung Circ. 2021. PMID: 34742544 Free PMC article. No abstract available.
-
Prevalence of Obesity-Related Disease in a Danish Population - The Results of an Algorithm-Based Screening Program.Diabetes Metab Syndr Obes. 2024 Jun 19;17:2505-2517. doi: 10.2147/DMSO.S456028. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38910914 Free PMC article.
-
Blood Pressure on Ambulatory Monitoring and Risk for Cardiovascular Disease and All-Cause Mortality: Ecological Validity or Measurement Reliability?Am J Hypertens. 2025 Jan 16;38(2):111-119. doi: 10.1093/ajh/hpae133. Am J Hypertens. 2025. PMID: 39400064 Free PMC article.
-
Masked Hypertension: Lessons for the Future.Ulster Med J. 2020 Sep;89(2):77-82. Epub 2020 Oct 21. Ulster Med J. 2020. PMID: 33093691 Free PMC article. Review.
-
Guide de pratique clinique en soins de première ligne d'Hypertension Canada pour le diagnostic et le traitement de l'hypertension artérielle chez les adultes.Can Fam Physician. 2025 Jul-Aug;71(7-8):e167-e184. doi: 10.46747/cfp.710708e167. Can Fam Physician. 2025. PMID: 40730439 Free PMC article. Review. English.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous